Venture capital firm Atomico has stepped up to lead a $10 million investment into ChemistDirect.
AIM-listed investment firm Imperial Innovations Group has secured a £30 million loan so that it can make investments in the biotech and therapeutics sectors.
A thirty one-year old specialist furniture business has taken on private equity backing as it looks to grow through organic and acquisitive means.
The £25 million North West Fund for Biomedical has made its 57th investment to date through the backing of Perfectus Biomed.
An $11 million investment from Index Ventures will be used to develop an anticoagulant drug aimed at preventing heart attacks and strokes without causing bleeding.
Growth Capital Partners portfolio company Fishawack has completed its first acquisition since the private equity firm backed a secondary buy-out at the company back in March.
A new collaboration between Alliance Boots and BioCity will see the creation of a new business incubator focused on health and wellness.
Octopus Investments has led a £2 million investment into clinical trials platform TrialReach alongside Amadeus Capital Partners.
Cerus Endovascular is moving its operations to Liverpool Science Park following backing from The North West Fund for Biomedical.
Care home operator Springfield Healthcare Group has already begun to use its Business Growth Fund cash to get acquisitive. We find out how progress has been since the investment as part of an exclusive portfolio roundtable.
Neuropsychological testing business Cambridge Cognition has joined London's Alternative Investment Market.
Business Growth Fund portfolio company Springfield Homecare Services has closed its first acquisition since the business was supported by the bank-backed fund in June 2012.
The private equity firm behind investments in Wagamama and Paperchase has sold its stake in Optimum Care through a trade sale.
Two new investments for Mercia Fund Management has kicked off its Mercia Growth Fund 1 efforts.
A £5 million investment from Isis Equity Partners' Baronsmead VCTs will be used to aid the development of a new fertility clinic for Create Health.
Medical communications agency Fishawack has a new private equity backer through a secondary buy-out deal.
Scottish medical technologies company Taragenyx has secured itself £1.3 million of seed capital to speed up the development of its orthopaedic and dental implant coatings.
A £25 million fundraising for infirst HEALTHCARE will be used to launch the company's medicines into the US market.
A first joint venture hospital acquisition between the NHS and a private healthcare provider has resulted in the purchase of a mental health rehabilitation institution.
A £1 million investment from The North West Fund for Biomedical is set to be used by Diagnostic Healthcare to expand its portfolio of medical equipment.
From working in a bar in Australia and needing a suit for job interviews, Elliot Suiter is now building out a bespoke tailoring service making the most of a growing trend in online retail.
Fox Williams partner Peter Ashford and associate Evie Meleagos examine the issue of cross-border litigation and present the facilitators and impediments.
It's that time of the year again, when George Osborne unveils his latest batch of economy boosting ingredients.